Fused heterocyclic compounds as s1p modulators
Номер патента: EP3341369A1
Опубликовано: 04-07-2018
Автор(ы): Charles Hutchins, Elizabeth Van Der Kam, Frank OELLIEN, Hervé Geneste, Jeroen VAN BERGEIJK, Mario Mezler, Michael Ochse, Patrick WALLESER, Sean Turner, Udo Lange, Wilfried Hornberger, Wilhelm Amberg
Принадлежит: AbbVie Deutschland GmbH and Co KG, AbbVie Inc
Опубликовано: 04-07-2018
Автор(ы): Charles Hutchins, Elizabeth Van Der Kam, Frank OELLIEN, Hervé Geneste, Jeroen VAN BERGEIJK, Mario Mezler, Michael Ochse, Patrick WALLESER, Sean Turner, Udo Lange, Wilfried Hornberger, Wilhelm Amberg
Принадлежит: AbbVie Deutschland GmbH and Co KG, AbbVie Inc
Реферат: The invention relates to heterocyclic compounds as S1P modulators, pharmaceutical compositions comprising such compounds, and uses thereof in the treatment, alleviation or prevention of diseases or disorders mediated by an S1P receptor.
Heterocyclic compounds and cognitive enhancers comprising the same as effective components
Номер патента: CA2436589C. Автор: Naoki Fukuda,Yoshimasa Yamaguchi,Toshiyuki Matsuno,Seiichiro Kawashima,Kenichi Saitoh,Masaya Higashi. Владелец: Zenyaku Kogyo KK. Дата публикации: 2010-10-19.